Ramzi M. Mohammad
Affiliations: | Wayne State University, Detroit, MI, United States |
Area:
Oncology, Molecular BiologyGoogle:
"Ramzi Mohammad"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bannoura SF, Aboukameel A, Khan HY, et al. (2023) Regulator of Chromosome Condensation (RCC1) a novel therapeutic target in pancreatic ductal adenocarcinoma drives tumor progression via the c-Myc-RCC1-Ran axis. Biorxiv : the Preprint Server For Biology |
| Uddin MH, Al-Hallak MN, Khan HY, et al. (2023) Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model. Clinical and Translational Medicine. 13: e1513 |
| Khan HY, Nagasaka M, Aboukameel A, et al. (2023) Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancers. Molecular Cancer Therapeutics |
| Khan HY, Nagasaka M, Aboukameel A, et al. (2023) Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancers. Biorxiv : the Preprint Server For Biology |
| Khan HY, Nagasaka M, Li Y, et al. (2022) Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C-Mutant Cancers. Cancer Research Communications. 2: 342-352 |
| Khan HY, Uddin MH, Balasubramanian SK, et al. (2021) PAK4 and NAMPT as Novel Therapeutic Targets in Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Mantle Cell Lymphoma. Cancers. 14 |
| Mpilla GB, Uddin MH, Al-Hallak MN, et al. (2021) PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to Everolimus. Molecular Cancer Therapeutics |
| Balasubramanian SK, Khan H, Uddin MH, et al. (2021) Dual Targeting PAK4 and NAMPT As a Novel Therapeutic Approach for Aggressive Non-Hodgkin's Lymphoma Blood. 138: 683-683 |
| Khan HY, Mpilla GB, Sexton R, et al. (2020) Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor Growth. Cancers. 12 |
| Khan HY, Ge J, Nagasaka M, et al. (2019) Targeting XPO1 and PAK4 in 8505C Anaplastic Thyroid Cancer Cells: Putative Implications for Overcoming Lenvatinib Therapy Resistance. International Journal of Molecular Sciences. 21 |